Literature DB >> 8844630

A menopause-specific quality of life questionnaire: development and psychometric properties.

J R Hilditch1, J Lewis, A Peter, B van Maris, A Ross, E Franssen, G H Guyatt, P G Norton, E Dunn.   

Abstract

OBJECTIVE: To develop a condition-specific quality of life questionnaire for the menopause with documented psychometric properties, based on women's experience.
SUBJECTS: Women 2-7 years post-menopause with a uterus and not currently on hormone replacement therapy. Questionnaire development: A list of 106 menopause symptoms was reduced using the importance score method. Replies to the item-reduction questionnaire from 88 women resulted in a 30-item questionnaire with four domains, vasomotor, physical, psychosocial and sexual, and a global quality of life question. Psychometric properties: A separate sample of 20 women was used to determine face validity, and a panel of experts was used to confirm content validity. Reliability, responsiveness and construct validity were determined within the context of a randomized controlled trial. Construct validation involved comparison with the Neugarten and Kraines'Somatic, Psychosomatic and Psychologic subscales, the reported intensity of hot flushes, the General Well-Being Schedule, Channon and Ballinger's Vaginal Symptoms Score and Libido Index, and the Life Satisfaction Index.
RESULTS: The face validity score was 4.7 out of a possible 5. Content validity was confirmed. Test-retest reliability measures, using intraclass correlation coefficients were 0.81, 0.79, 0.70 and 0.55 for the physical, psychosocial, sexual domains and the quality of life question. The intraclass correlation coefficient for the vasomotor domain was 0.37 but there is evidence of systematic change. Discriminative construct validity showed correlation coefficients of 0.69 for the physical domain, 0.66 and 0.40 for the vasomotor domain, 0.65 and -0.71 for the psychosocial domain, 0.48 and 0.38 for the sexual domain, and 0.57 for the quality of life question. Evaluative construct validity showed correlation coefficients of 0.60 for the physical domain, 0.28 for the vasomotor domain, 0.55 and -0.54 for the psychosocial domain, 0.54 and 0.32 for the sexual domain, and 0.12 for the quality of life question. Responsiveness scores ranged from 0.78 to 1.34.
CONCLUSIONS: The MENQOL (Menopause-Specific Quality of Life) questionnaire is a self-administered instrument which functions well in differentiating between women according to their quality of life and in measuring changes in their quality of life.

Entities:  

Mesh:

Year:  1996        PMID: 8844630     DOI: 10.1016/s0378-5122(96)82006-8

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  135 in total

Review 1.  Effect of SERMs on the uterus and menopausal symptoms.

Authors:  M Dören
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.

Authors:  Debra L Barton; Kelliann C Fee Schroeder; Tanima Banerjee; Sherry Wolf; Timothy Z Keith; Gary Elkins
Journal:  Menopause       Date:  2017-07       Impact factor: 2.953

3.  The Menopause-Specific Quality of Life Questionnaire: psychometric evaluation among breast cancer survivors.

Authors:  Jill V Radtke; Lauren Terhorst; Susan M Cohen
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

4.  Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial.

Authors:  Vikki Ho; Romain Pasquet; Shaman Luo; Gang Chen; Paul Goss; Dongsheng Tu; Philip Lazarus; Harriet Richardson
Journal:  Breast Cancer Res Treat       Date:  2020-08-01       Impact factor: 4.872

5.  Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.

Authors:  Susan J Diem; Katherine A Guthrie; Caroline M Mitchell; Susan D Reed; Joseph C Larson; Kristine E Ensrud; Andrea Z LaCroix
Journal:  Menopause       Date:  2018-10       Impact factor: 2.953

6.  Quality of life after the menopause in Iran: a population study.

Authors:  Hossien Fallahzadeh
Journal:  Qual Life Res       Date:  2010-04-01       Impact factor: 4.147

Review 7.  Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review.

Authors:  Annette J Thomas; Rita Ismail; Lisa Taylor-Swanson; Lori Cray; Janet G Schnall; Ellen Sullivan Mitchell; Nancy Fugate Woods
Journal:  Maturitas       Date:  2014-05-28       Impact factor: 4.342

Review 8.  Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.

Authors:  Sylvain L'Espérance; Suzanne Frenette; Anne Dionne; Jean-Yves Dionne
Journal:  Support Care Cancer       Date:  2013-02-23       Impact factor: 3.603

9.  Ramelteon for the treatment of insomnia in menopausal women.

Authors:  Roseanne DeFronzo Dobkin; Matthew Menza; Karina L Bienfait; Lesley A Allen; Humberto Marin; Michael A Gara
Journal:  Menopause Int       Date:  2009-03

10.  Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.

Authors:  Caroline M Mitchell; Susan D Reed; Susan Diem; Joseph C Larson; Katherine M Newton; Kristine E Ensrud; Andrea Z LaCroix; Bette Caan; Katherine A Guthrie
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.